<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="1256">
  <stage>Registered</stage>
  <submitdate>3/05/2006</submitdate>
  <approvaldate>4/05/2006</approvaldate>
  <actrnumber>ACTRN12606000158561</actrnumber>
  <trial_identification>
    <studytitle>Impact of regular exercise during haemodialysis on arterial stiffness</studytitle>
    <scientifictitle>Improvement of arterial compliance with regular exercise during haemodialysis</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Cardiovascular disease and arterial stiffness in haemodialysis patients</healthcondition>
    <conditioncode>
      <conditioncode1>Cardiovascular</conditioncode1>
      <conditioncode2>Other cardiovascular diseases</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>The implementation of regular exercise during haemodialysis sessions.                                                                                                                                                                                                 Regular exercise will be in the form of pedal bicycle ergometry, one hour on dialysis, 3 times weekly for 3 months. Cross-over will occur at 3 months with a one week wash-out period in between the exercise and no exercise arms.</interventions>
    <comparator>No exercise</comparator>
    <control>Active</control>
    <interventioncode>Lifestyle</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Improvement in arterial compliance</outcome>
      <timepoint>After 3 months of exercise</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Changes in serum parameters of anaemia and mineral metabolism.</outcome>
      <timepoint>After 3 months of exercise.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Adult conventional haemodialysis patients (3-5hrs, 3x weekly).</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>85</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Active respiratory disease or ischaemic heart disease, unable to execise with a pedal bicycle ergometer, unable to give infomed consent.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence />
    <masking>Open (masking not used)</masking>
    <assignment>Crossover</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>1/06/2006</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>20</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Dr Nigel Toussaint, Department of Nephrology, Monash Medical Centre</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Department of Nephrology, Monash Medical Centre</fundingname>
      <fundingaddress />
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>Nil</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Assessing the impact of exercise (one hour, 3 times weekly on dialysis) using a bicycle ergometer for 3 months, on arterial stiffness (and therefore cardiovascular health) in patients on haemodialysis. Using pulse wave velocity (non invasive applanation tonometry) to measure the changes in degree of arterial siffness</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Not yet submitted</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Southern Health Ethics Committee-Monash Medical Centre</ethicname>
      <ethicaddress>Clayton, Victoria</ethicaddress>
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Nigel Toussaint</name>
      <address>Department of Nephrology
Monash Medical Centre
246 Clayton Rd
Clayton VIC 3168</address>
      <phone>+61 3 95943533</phone>
      <fax />
      <email>nigel.toussaint@med.monash.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Nigel Toussaint</name>
      <address>Department of Nephrology
Monash Medical Centre
246 Clayton Rd
Clayton VIC 3168</address>
      <phone>+61 3 95943533</phone>
      <fax />
      <email>nigel.toussaint@med.monash.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>